Weight Loss Modest With Primary Care Program
December 1, 2011|Clinical Endocrinology News
Author and Disclosure Information
From The New England Journal Of Medicine
There were 73 hospitalizations for severe adverse events, with no significant differences among the three study groups.
Only three such events were deemed to be possibly related to the intervention: two cholecystectomies, and one case of syncope. In addition, sibutramine was discontinued in seven patients because of blood pressure elevation, tachycardia, or anxiety; and orlistat was discontinued in five patients because of gastrointestinal symptoms.
“Although our study has shown that primary care personnel can provide effective weight-management support, it has not addressed the more challenging question of who will pay for these or related weight-loss interventions,” the researchers noted.
